SCHEMBL30740694

SCHEMBL30740694

COC(=O)c1cc(C)ccc1OCc1cccc(CC2CCCCN2C(=O)OC(C)(C)C)n1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HCRTR2 O43614 8/20 0.41
▸ HCRTR1 O43613 5/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ PRMT5 O14744 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ METTL3 Q86U44 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ KDM1A O60341 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ MRGPRX4 Q96LA9 1/20 0.37
▸ CHEK2 O96017 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30740841 0.87 L3MBTL1 (0.38) HCRTR2HCRTR1NPSR1LMNAL3MBTL1
SCHEMBL30740738 0.85 PRMT5 (0.38) HCRTR2HCRTR1NPSR1LMNAL3MBTL1
SCHEMBL29826374 0.85 GPR119 (0.43) LMNAKMT2AMEN1MAPTKDM4E
SCHEMBL30740732 0.80 MRGPRX4 (0.45) LMNAPRMT5KDM1AMRGPRX4CHEK2
SCHEMBL30740781 0.78 KDM1A (0.44) HCRTR2NPSR1LMNAKMT2APRMT5
SCHEMBL29826235 0.71 GPR119 (0.45) LMNAKMT2AKDM4E
SCHEMBL29826499 0.70 GPR119 (0.46) LMNAKMT2AKDM4E
SCHEMBL25155946 0.69 ALOX5AP (0.43) NPSR1LMNAKMT2APRMT5MEN1
SCHEMBL31359908 0.69 ALOX5AP (0.43) NPSR1LMNAKMT2APRMT5MEN1
SCHEMBL31360101 0.69 ALOX5AP (0.43) NPSR1LMNAKMT2APRMT5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117043154-A GPCR receptor agonists, pharmaceutical compositions comprising same, and methods of use thereof 卡莫特医疗有限公司 2023-11-10 — — CN disclosed
Send feedback